Indian vaccine innovation: the case of Shantha Biotechnics
<p>Abstract</p> <p>Background</p> <p>Although the World Health Organization had recommended that every child be vaccinated for Hepatitis B by the early 1980s, large multinational pharmaceutical companies held monopolies on the recombinant Hepatitis B vaccine. At a price...
Saved in:
Main Authors: | Heys Jennifer (Author), Perampaladas Kumar (Author), Masum Hassan (Author), Chakma Justin (Author), Singer Peter A (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling Biotechnical Systems in Sports
by: А. О. Лопатьєв, et al.
Published: (2017) -
Venture funding for science-based African health innovation
by: Daar Abdallah S, et al.
Published: (2010) -
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model
by: Singer Peter A, et al.
Published: (2010) -
Franchising rabies vaccine delivery: the case of Indian immunologicals.
by: Hassan Masum, et al.
Published: (2011) -
Turning science into health solutions: KEMRI's challenges as Kenya's health product pathfinder
by: Chakma Justin, et al.
Published: (2010)